For investors only
All about the drug candidate arfolitixorin
and related information
ESMO 2018, poster
Isofol will attend at ESMO 2018 Congress in Munich, Germany, October 19-23. During this meeting the poster, “ISO-CC-005; a phase I/II study of arfolitixorin ([6R]-5,10-MTHF) in combination with 5-fluorouracil (5-FU), irinotecan and oxaliplatin ± bevacizumab in patients with metastasizing colorectal cancer ”, will be presented.
The poster will be exposed on October 21 at 09:00 in Hall A3 with the poster no 569P. At that same time you are able to download it here:
Poster, ESMO meeting 2018 (1 265 kB)
Last updated 05-22-2024
